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objective diagnostic findings are conspicuously absent.
The term disputed NTOS was introduced by Wilbourn2 to
apply to this group of patients.
Few would argue that surgical decompression of the
thoracic outlet is indicated in patients with objectively
diagnosed neurogenic, arterial, or venous thoracic outlet
syndrome. It is also clear that these objectively diagnosed
entities are rare, and that most thoracic outlet decompres-
sion procedures for thoracic outlet syndrome are currently
performed for patients with the disputed form of NTOS.
Objective critical data on the success of such treatment are
conspicuously lacking. Although a number of surgeons
have made claims of initial dramatic improvement in
patients’ symptoms,3-10 the long-term outcome of these
patients is unknown. Outcome data have almost always
been reported by the operating surgeon, hardly a disinter-
ested observer. Independent reporting of patient out-
comes by those not involved in their care is rare. Several
recent reports have focused on the conservative manage-
ment of patients with symptoms of NTOS,11-15 and favor-
able results have been described. Despite broad acceptance
by some surgeons for operative therapy of NTOS, the
superiority of surgical therapy over conservative manage-
ment has never been clearly demonstrated. 
The diagnosis and management of neurogenic tho-
racic outlet syndrome (NTOS) remain enigmatic. The
diagnostic criteria for “true” NTOS were outlined by
Gilliatt et al in 1970.1 A combination of anatomic and
electrodiagnostic findings was necessary to firmly establish
this diagnosis. Since the publication of this definitive
work, it has become increasingly evident that a minority of
patients who have received the diagnosis of NTOS has met
the diagnostic criteria of Gilliatt. All vascular specialists are
familiar with the group of patients presenting with com-
plaints of upper extremity pain and paresthesias in whom
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Purpose: Neurogenic thoracic outlet syndrome (NTOS) in the absence of bony and electrodiagnostic abnormalities,
often referred to as disputed NTOS, remains enigmatic. Optimal treatment, especially the role of surgery, is controver-
sial. The long-term functional outcome of a cohort of patients undergoing independent medical examination for dis-
puted NTOS with symptoms sufficiently severe to cause inability to work forms the basis for this report.
Methods: Patients with disputed NTOS and symptoms sufficiently severe to cause at least temporary inability to work
seen for independent medical examinations from 1990-1998 formed the study group. None of the patients were treated
by our group. Functional outcome was assessed with information from a standardized telephone interview or patient
questionnaire. The patients’ ability to return to work and an assessment of their current level of symptoms and symp-
tom progression since the time of onset were determined.
Results: Seventy-nine patients were reevaluated at a mean follow-up of 4.2 years (range, 2-7.5 years) after our initial
evaluation. Fifteen patients (19%) underwent first rib resection surgery performed by others, whereas 64 (81%) had no
surgery. Patients undergoing surgery had missed more work time than those undergoing conservative management
(27.6 ± 6.0 months vs 14.9 ± 2.6 months, P < .04). Return to work was achieved in nine patients who were operated
on (60%) and in 50 patients who were not operated on (78%) (P = not significant [NS]). Among operated patients,
current assessment of symptom severity was severe, moderate, mild, and asymptomatic in 7%, 47%, 40% and 7%, respec-
tively. This distribution did not differ significantly from that observed in nonoperated patients (11%, 55%, 30%, 5%; P
= NS). When asked about changes in symptomatic status since onset, 7% of the operated group had complete resolu-
tion, 27% had marked improvement, 40% had minimal improvement, 13% had no improvement, and 13% were worse.
This did not differ significantly from the change in symptoms reported by the nonoperated group (2%, 30%, 22%, 31%,
16%; P = NS).
Conclusion: Most patients with disputed NTOS in this nonrandomized series were able to return to work and demon-
strated an improvement of symptoms with long-term follow-up. First rib resection did not improve functional outcome
in this group. (J Vasc Surg 2001;33:312-9.)
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Perhaps most important, the natural history of the
untreated disease is substantially unknown. Although it is
clear that objectively documented brachial plexopathies
ultimately lead to chronic axonal loss and muscle wast-
ing,16 a similar natural history for the disputed form of
NTOS has never been demonstrated, a point of consider-
able interest. In fact, the functional outcome of this group
of patients is unknown, surprisingly.
We have evaluated many patients referred with a pre-
sumptive diagnosis of NTOS, most of whom have the dis-
puted variant of NTOS. These patients were referred to us
by other physicians for evaluation or were referred by
workers’ compensation insurance companies for indepen-
dent medical examinations. No patients underwent treat-
ment at our institution. The long-term functional
outcome of patients with disputed NTOS in terms of cur-
rent level of symptoms, improvement of symptoms since
their onset, and ability to return to work forms the basis
of this report.
METHODS
From 1990-1998, 153 patients with a presenting
diagnosis of NTOS were evaluated by the vascular surgery
service at the Oregon Health Sciences University. The ini-
tial evaluation consisted of each patient providing a com-
plete history and undergoing a physical examination. All
patients were also seen by a neurologist and underwent
electrodiagnostic testing, including nerve conduction
studies and electromyography. Vascular laboratory testing
and further imaging studies (plain radiographs, computer-
ized tomography scans, and magnetic resonance imaging)
were performed as indicated. All patients were both ini-
tially and subsequently treated by other physicians.
Conservative and operative management was chosen at
the discretion of the patients’ physicians.
For the current study, all patients with electrodiagnos-
tic evidence of true NTOS as described by Gilliatt were
excluded from analysis. Electrodiagnostic positivity was
determined by decreased amplitude of the median motor,
ulnar sensory,1 and often median antebrachial cutaneous
action potentials,17 usually accompanied by electromyo-
graphic evidence of denervation of the lower trunk inner-
vated hand muscles, particularly the abductor pollicis
brevis. Additionally, only those patients whose symptoms
were sufficiently severe to cause at least a temporary inabil-
ity to work were included. 
Follow-up information was obtained from the patients
by means of either a standardized mailed questionnaire or
standardized telephone interview. All subjects were mailed
a questionnaire. An attempt was then made to reach
patients not responding to the questionnaire by tele-
phone. The same questionnaire was used in both methods
of interrogation. An example of the questionnaire used is
included in the Appendix. The interviewing physician did
not participate in the patients’ initial evaluation. Patients
were asked about the severity and frequency of their cur-
rent level of symptoms. Severity of symptoms was ranked
as severe, moderate, minimal, or no symptoms. Patients
were asked to estimate their degree of improvement in
comparison with their initial presentation. Improvement
was classified as complete resolution, marked improve-
ment, minimal improvement, no improvement, or wors-
ening of symptoms. Patients were also asked about
methods of treatment they received and the degree of
benefit obtained from treatment. Functional status was
evaluated by the patients’ current ability to perform their
work. Patients who underwent thoracic outlet decompres-
sive operations were then compared with those who did
not with respect to the previous observations.
All data were entered into a confidential computerized
database (Paradox for Windows, Version 5.0; Borland
International, Scotts Valley, Calif). Continuous variables
were compared with the Student t test. Comparisons of
frequencies and proportions were performed with a χ2
test. Statistical significance was defined as a P value less
than .05.
RESULTS
Patient demographics. Of 153 patients evaluated,
one was excluded because the patient had electrodiagnos-
tic evidence of true NTOS. Seventeen patients were
excluded because they had not lost work time because of
their symptoms. Of the remaining 135 patients interro-
gated, 79 responded to either the mailed questionnaire or
phone interview, for a 59% response rate. The inability to
locate the remaining patients characterized the nonrespon-
der group. Sixty-four patients had received only nonopera-
tive treatment, whereas 15 underwent operative therapy.
Demographic information for these groups is listed in
Table I. There were no significant differences between the
surgical, nonsurgical, and excluded patients and patients
lost to follow-up in sex, race, occupation, and involvement
in litigation. Patients undergoing surgery were significantly
older than those lost to follow-up (40.5 ± 1.8 years vs 35.0
± 1.0 years, P < .05), but no other age differences between
the groups were noted. The mean length of follow-up from
the time of our initial evaluation was 4.2 ± 0.5 years (range,
2-7.5) in the patients who were operated on and 4.2 ± 0.2
years (range, 2-7.5) in the patients who were not operated
on (P = not significant [NS]).
Symptoms. Patients’ symptoms at the time of initial
evaluation are listed in Table II. The types of symptoms
experienced were the same in both groups. Operated
patients had more frequent complaints of neck pain (60%
vs 27%, P < .03). No other difference in the location of
symptoms was noted. Primarily unilateral symptoms were
present in 60% of the operated group and 77% of the non-
operated group (P = NS). Sixty-seven percent of the oper-
ated group could relate the onset of their symptoms to a
specific time or event, whereas 33% thought that their
symptoms were of gradual onset. Corresponding percent-
ages in the nonoperated group were 44% and 56% (P =
NS). The duration of the patients’ symptoms before our
initial evaluation was longer in the surgically treated group
(4.0 ± 1.2 years) than in the nonsurgically treated group
(2.1 ± 0.3 years, P < .02).
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Prior assessment and treatment. The initial nonop-
erative management of all patients is represented in Table
III. Patients who underwent surgery had seen more physi-
cians (6.7 ± 0.9) than those treated nonoperatively (4.3 ±
0.3, P < .002). There was no difference between surgically
and nonsurgically treated patients in treatment by a phys-
ical therapist (80% vs 67%, respectively, P = NS) or a chi-
ropractor (20% each group). Those who underwent
surgery had been treated with significantly more types of
medications than those treated nonoperatively (3.1 ± 0.3
vs 1.9 ± 0.2, P < .001). Although most patients in each
group had been treated with nonsteroidal anti-inflamma-
tory drugs (NSAIDs), patients undergoing surgery were
more likely to also have been treated with narcotic anal-
gesics (67% vs 30%, P < .01), muscle relaxants (60% vs
27%, P < .01), and antidepressants (53% vs 22%, P < .01). 
Operative therapy. Fifteen patients underwent oper-
ative therapy by other surgeons. Fourteen underwent first
rib resections, and one underwent a combined cervical
and first rib resection. The duration of conservative man-
agement before operative therapy was 3.7 ± 1.0 years. The
length of follow-up after surgery was 3.9 ± 0.6 years.
Current level of symptoms. The patients’ current
level of symptoms is shown in Table IV. In the operated
group, 7% currently have severe symptoms, 47% have
moderate symptoms, 40% have mild symptoms, and 7%
are asymptomatic. Corresponding percentages in the non-
operated group are 11%, 55%, 30%, and 5% (P = NS).
With these distributions and power analysis for the χ2 test,
Table I. Demographic information on patients diagnosed with NTOS
Survey responders (n = 79)
Demographic factor Surgical (n= 15) Nonsurgical (n = 64) Excluded* (n = 17) LTFU (n = 56)
Age when first seen (y ± SEM) 40.5 ± 1.8† 37.9 ± 1.1 37.9 ± 2.0 35.0 ± 1.0
Sex (% female) 11 (73%) 36 (56%) 10 (59%) 39 (70%)
Race (% white) 15 (100%) 58 (91%) 16 (94%) 52 (93%)
Occupation
Manual 8 (53%) 45 (70%) 10 (59%) 39 (70%)
Office/secretarial 4 (27%) 7 (11%) 4 (24%) 6 (11%)
Other 3 (20%) 12 (19%) 3 (18%) 11 (20%)
Involved in litigation (% yes) 9 (60%) 50 (78%) 13 (77%) 48 (86%)
Length of follow-up (y ± SEM) 4.2 ± 0.5 4.2 ± 0.2 NA NA
*Includes patients whose symptoms were not severe enough to cause work cessation.
†P < .05 between patients treated surgically and patients lost to follow up.
LTFU, Lost to follow-up; NA, not applicable; NTOS, neurogenic thoracic outlet syndrome.
Table II. Nature and site of symptoms in the 79 respondents with NTOS
Surgical group (n = 15) Nonsurgical group (n = 64) P value
Symptom
Pain 15 (100%) 56 (88%) NS
Paresthesias 11 (73%) 55 (86%) NS
Weakness 3 (20%) 15 (23%) NS
Swelling 3 (20%) 5 (8%) NS
Site
Neck 9 (60%) 17 (27%) < .03
Shoulder 12 (80%) 44 (69%) NS
Arm 14 (93%) 52 (81%) NS
Forearm 15 (100%) 59 (92%) NS
Hand 14 (93%) 58 (91%) NS
Fingers 8 (53%) 40 (63%) NS
Table III. Initial nonoperative management of operated
and nonoperated patients
Operated Nonoperated
(n = 15) (n = 64) P value
Total physicians seen 6.7 ± 0.9 4.3 ± 0.3 < .002
Physical therapy 12 (80%) 43 (67%) NS
Chiropractor 3 (20%) 13 (20%) NS
Medications prescribed 3.1 ± 0.3 1.9 ± 0.2 < .001
Medication types
NSAID 13 (87%) 52 (81%) NS
Narcotics 10 (67%) 19 (30%) < .01
Muscle relaxants 9 (60%) 17 (27%) < .01
Antidepressants 8 (53%) 14 (22%) < .03
NNA 2 (13%) 6 (9%) NS
other 4 (26%) 10 (16%) NS
Values are mean ± SEM or number (%).
NNA, Nonnarcotic analgesic; NSAID, nonsteroidal anti-inflammatory
drug.
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we calculated that a sample size of 19,900 subjects would
be required to demonstrate a difference between the sur-
gical and nonsurgical groups with power equal to 80%.
Progression of symptoms since onset. The progres-
sion of patient symptoms since onset is shown in Table IV.
In the surgically treated group, 7% believe that their symp-
toms are resolved, 27% have had a marked improvement,
40% have had minimal improvement, 13% have had no
improvement, and 13% believe that they are worse.
Corresponding percentages in the nonoperated patients
are 2%, 30%, 22%, 31%, and 16% (P = NS). With these dis-
tributions and power analysis for the χ2 test, we calculated
that a sample size of 1900 subjects would be required to
demonstrate a difference between the surgical and non-
surgical groups with power equal to 80%.
Outcome based on occupation. The patients’ cur-
rent level of symptoms and symptom progression based on
occupation is shown in Table V. No differences in out-
come were noted.
Ability to return to work. Total work time missed
was statistically greater in the operated than in the nonop-
erated group (27.6 ± 6.0 months vs 14.9 ± 2.6 months, P
< .04). Nine of the operated patients (60%) have returned
to work compared with 50 (78%) of the nonoperated
patients (P = NS).
Current medication requirements. The current
medication requirements of operated and nonoperated
patients are listed in Table VI. There were no differences
in the long-term medication requirements of operated and
nonoperated patients.
DISCUSSION
In this study, we have reported the results of our mod-
est experience with the evaluation and follow-up of
patients given a diagnosis of disputed or electronegative
NTOS. Follow-up data were attained in 79 patients, of
whom 15 had undergone surgical thoracic outlet decom-
pression and 64 received nonoperative therapy. After a
mean follow-up in both groups of 4.2 years since our ini-
tial evaluation, no significant difference could be detected
in the current level of symptoms, disease progression since
onset, and ability to return to work. Clearly, there are lim-
itations to these data. Follow-up data were available in
only 59% of patients. Patients were not randomized but,
rather, were treated at the discretion of their own physi-
cians. One could argue that because the operated patients
had a longer duration of symptoms and missed work, as
well as seeing more physicians and requiring more med-
ications, that the patients with the most severe disease
were the ones who underwent surgery. However, an alter-
native hypothesis would be that those patients who are
persistent in their complaints will ultimately find a surgeon
willing to perform thoracic outlet decompression.
Regardless of the cause, in this small series, surgical ther-
apy did not have a significant impact on functional out-
come. We acknowledge that the small size of the surgical
group could be the source of a type II error.
Other limitations in these data are noteworthy.
Because patients did not fill out a questionnaire at the time
of their initial evaluation, no direct comparison between
their initial and subsequent symptoms could be made.
Clearly, retrospective questionnaires are not the ideal
method of performing outcomes analysis; prospective
studies are the gold standard. Also, the questionnaire used
has not been validated and, therefore, may be subject to
variability. Similar questionnaires have been used in other
studies, and we thought that the questions were specific
enough so that patients could classify the nature of their
symptoms and symptom progression.
Because those who underwent surgery had their
operation performed elsewhere, we cannot verify the
quality or completeness of resection. However, in
another recent report, patient outcome was unrelated to
the volume of thoracic outlet surgery performed by
individual surgeons.18
Although the etiology, diagnosis, and pathophysiology
of NTOS remain controversial, opinions regarding opti-
mal treatment are abundant. Numerous surgical case series
have been reported that have claimed good to excellent
results in 50% to 90% of patients undergoing thoracic out-
let decompression.3-10 The length of follow-up in these
studies is variable. There are two noteworthy facts. First,
Table IV. Outcome based on treatment received
Current level of symptoms in operated and nonoperated patients
Severe Moderate Minimal Asymptomatic
Operated (n = 15) 1 (7%) 7 (47%) 6 (40%) 1 (7%)
Nonoperated (n = 64) 7 (11%) 35 (55%) 19 (30%) 3 (5%)
Progression of symptoms since onset in operated and nonoperated patients
Resolved Marked improvement Minimal improvement No improvement Worse
Operated (n = 15) 1 (7%) 4 (27%) 6 (40%) 2 (13%) 2 (13%)
Nonoperated (n = 64) 1 (2%) 19 (30%) 14 (22%) 20 (31%) 10 (16%)
P = NS between the operated and nonoperated group.
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the results are reported by the operating surgeon, which
potentially introduces bias because functional results can
only be reported in subjective terms. Recent articles in
which operative results were reviewed by a third party have
been slightly less promising. Lepäntalo et al19 reported
follow-up of 75 patients undergoing first rib resections.
One month after surgery, 52% of limbs were asympto-
matic, and 77% were improved. At a mean follow-up of 6
years, patients were reevaluated by independent examin-
ers. A permanent success rate of the operation of only 37%
was reported. The authors emphasized the importance of
an unbiased evaluation and long-term follow-up.
The second criticism of heretofore published surgical
case series is the distinct lack of a nonsurgical control
group for comparison. We are aware of only one other
report in which a group of surgically and nonsurgically
treated patients was compared. Franklin et al18 reported
the outcome of patients involved in worker’s compensa-
tion undergoing thoracic outlet surgery. At 1, 2, and 5
years after surgery, the percentage of patients still on dis-
ability leave from work was 60%, 40%, and 44%, respec-
tively. In 100 patients followed up for an average of 4.8
years, 63.5% thought that their symptoms were
unchanged or worse, and 72.5% thought that they were
still “limited a lot” in vigorous activities. In comparison
with 95 matched control patients with thoracic outlet syn-
drome who underwent conservative therapy, patients who
underwent surgery had a 50% increase in health care costs
and were three to four times more likely to be unable to
return to work. 
The association between a poor clinical outcome and
worker’s compensation claims has been previously made.
Green et al20 reported that only 36% of worker’s compen-
sation patients compared with 57% of noncompensated
patients could return to their preillness function. Good
surgical outcomes were reported in 66% of nonlaborers
compared with 23% of laborers by Goff et al.21 Only 30%
of laborers were able to return to their previous occupa-
tion compared with 65% of nonlaborers. In this study, no
differences in outcome were detected on the basis of occu-
pation or involvement in litigation.
Although reports of surgical management of NTOS
are abundant, few reports of patient outcome after con-
servative management have been published. Novak et al12
reported 1-year follow-up of 42 patients who had under-
gone a 6-month program of physical therapy for NTOS.
Twenty-five patients (60%) thought that their overall
symptoms were better than before treatment. Overall,
pain relief was thought to be complete in three patients,
almost complete in 16, and partial in 19; there was no
improvement in four. Overall, 78% of patients were able to
resume work. Factors that were significantly associated
with a worse outcome were obesity, involvement in a
workers’ compensation claim, and associated carpal or
cubital tunnel syndrome. 
Lindgren11 reported a 2-year follow-up of 119
patients who underwent inpatient rehabilitation for a
mean of 11.4 days followed by a home exercise program.
At follow-up, 88% were satisfied with the outcome of their
treatment, and 73% had returned to work. Kenny et al15
evaluated eight patients with severe neck and upper
extremity range of motion limitations. After 3 weeks of
intensive physical therapy, full neck and shoulder range of
motion was restored in all patients.
The controversy of surgical versus nonsurgical treat-
ment of disputed NTOS continues. Although each side has
its advocates, the only definitive method of resolving this
conflict is a randomized, prospective trial comparing the
Table V. Patient outcome based on occupation
Manual laborers, n = 53 Nonmanual laborers (office, health care, etc) (n = 26)
Current level of symptoms
Severe 6 (11%) 2 (8%)
Moderate 31 (58%) 11 (42%)
Mild 15 (28%) 10 (38%)
None 1 (2%) 3 (12%)
Progression of symptoms
Resolved 0 (0%) 2 (8%)
Marked improvement 15 (28%) 8 (31%)
Minimal improvement 16 (30%) 4 (15%)
No improvement 14 (26%) 8 (31%)
Worse 8 (15%) 4 (15%)
P = NS between manual and nonmanual laborers,
Table VI. Current medication requirements in operated
and nonoperated patients
Operated patients Nonoperated patients
(n = 15) (n = 64)
NSAID 6 (40%) 31 (48%)
Narcotics 4 (27%) 14 (23%)
Muscle relaxants 5 (33%) 9 (14%)
Antidepressants 2 (13%) 10 (16%)
Acetaminophen 2 (13%) 3 (5%)
Aspirin 1 (7%) 7 (11%)
Other 3 (20%) 4 (6%)
None 2 (13%) 9 (14%)
P = NS between operated and nonoperated patients.
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two modalities. Although such a trial was initially proposed
in 1992,22 to date, no such trial has been performed. It has
been our observation that disputed NTOS is virtually never
seen in the elderly patient population. This implies that the
syndrome runs a self-limiting course. The overall improve-
ment noted in the nonoperated patients in this series sup-
ports the assumption that the natural history of disputed
NTOS is one of gradual improvement. It is essential that
the proponents of surgical treatment of disputed NTOS
prove that surgical therapy is superior to conservative man-
agement. Until such a time, we will continue to favor con-
servative therapy of disputed NTOS.
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Please see the Web site for the Appendix (www.mosby.
com/jvs).
Dr Asa Wilbourne (Cleveland, Ohio). This is an interesting
and timely article. It adds to a growing list of publications that
challenge certain concepts postulated by the proponents of dis-
puted neurologic TOS. It is important for two reasons. First, it
demonstrates that a significant number of TOS patients improve
with conservative therapy. Second, it shows that after a few years,
approximately the same percentage of patients improve regardless
of whether they are treated surgically or nonsurgically.
The authors were not the first to demonstrate that conservative
therapy is helpful. However, they have provided us with what was
lacking previously, namely, some percentages to work with. Thus, it
is now possible to explain to patients that regardless of whether they
undergo surgery, they have a one in three chance of having their
symptoms improve, possibly even disappear, over the next few years.
In regard to TOS treatment, Franklin and coworkers, in an
article published in Neurology this past March, reported on a 5-
year retrospective survey they had performed regarding the out-
come of patients with TOS who were treated in the workmen’s
compensation system in the state of Washington. They compared
patients who underwent surgery and those who did not and
found the surgical results overall to be dismal. Obviously, these
adverse surgical results can be questioned. In the present paper,
for example, only 15 patients underwent surgery, whereas more
than four times that number did not. Moreover, although it
appears that surgical versus nonsurgical management is deter-
mined principally by the orientation of the physicians caring for
the patient, the contention cannot be refuted that these two
groups may not be comparable, because the surgical group con-
sisted of patients with more severe disease.
There is a method, however, for resolving this controversy, by
performing a randomized, prospective trial comparing the two
types of TOS treatment. If substantial sustained improvement
were demonstrated in the surgical group, the evidence would be
overwhelming that, first, some disorder actually existed thereby
silencing those who are skeptical of this type of TOS and second,
that the appropriate therapy was surgical. Although such a trial
was proposed in the Journal of Vascular Surgery almost a decade
ago (1992), none of the proponents to this time, to our knowl-
edge, has initiated such a clinical trial. This is unfortunate
because, unlike so many other controversies in medicine, this is
one that can be resolved.
Dr Gregory J. Landry. I’d like to thank Dr Wilbourne for his
discussion, and I’m sorry that he couldn’t be here personally.
We certainly acknowledge the limitations in these data with
respect to the small numbers present in the surgical group. Our
purpose in presenting this was not to present it as a definitive
comparison between these two groups, but rather to suggest that
such a comparison needs to be made. As Dr Wilbourne elo-
quently pointed out in his discussion, to really address this issue
further, a randomized, prospective trial is needed.
DISCUSSION
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Dr Alan R. Koslow (Des Moines, Iowa). Very nice paper. I
want to ask you for your comments on the paper presented last
year at this meeting by the UCLA group at one of the breakfast
sessions in which they looked at their results of doing anterior sca-
lene muscle injection CT directed. And they compared their
results of operating on patients who had the historical type of
workup in which they had about a 60% to 70% success rate with
that surgery where they did not do the CT-directed muscle injec-
tion. In those patients who had successful relief of that pain with
the anterior muscle injection, they had a 90% success rate. And I
can attest that since then I’ve been evaluating my patients that
way, and I’ve done approximately a dozen patients. I have not had
a failure of good or excellent relief of symptoms using the CT-
directed muscle injection as a preoperative test. 
Dr Landry. Certainly the group at UCLA has done excellent
work in terms of the management of neurogenic thoracic outlet
syndrome, and I think that there may actually be subgroups of
patients who may benefit from more aggressive treatment. I think
our responsibility is to identify who belongs to those subgroups
so that those patients can be more definitively managed.
Dr Stephen J. Annest (Denver, Colo). My group in Denver
tends to take only those patients who are failures of physical ther-
apy, so in your paper that would have been 47% nonoperatively
managed patients who became worse or who had no benefit from
therapy. Looking at that group in our practice over the past 20
months, the first-time operations have a 16% rate of returning to
asymptomatic state, 42% had marked improvement, and 42%
noted only mild improvement. None of those patients were worse
or at the same level as before surgery. Eighty percent of those
operated said that they would have the operation again. In the
reoperated group who had had scarred brachial plexus from pre-
vious operations, 75% experienced marked improvement, only
25% had mild improvement, and no patient was worse. My ques-
tion to you is, in the 15 who had surgery, what were the selection
criteria by which patients were chosen for surgery?
Dr Landry. We were not involved with the treatment of these
patients. So in essence, from our standpoint, it was a bit random-
ized in that we did not have any influence over who was treated sur-
gically and who was not. That decision was made at the discretion
of each patient’s individual physician. I acknowledge that there may
be biases introduced by the opinions of each individual practitioner.
Dr Kaj H. Johansen (Seattle, Wash). Somewhere among all
the horse manure that surrounds the issue of thoracic outlet syn-
drome is a pony. I want to be sure, Dr Landry, that you are actu-
ally searching for that pony and not just piling more on.
Specifically, while I agree that your conclusions follow from
your analysis of your data, it is your selection criteria that concern
me here. Permit me to draw an analogy. A government-sponsored
panel of physicians analyzes a group of patients undergoing
amputation following bypass graft for limb salvage. The amputa-
tion obviously indicates that the procedure failed, and the con-
clusion is that bypass grafting really doesn’t work. The dilemma
with your selection process is that is based on subjects selected via
the process of independent medical evaluation (IME). The prob-
lem is that those who undergo an IME have an implicit conflict
or they have failed therapy. You have provided data regarding a
series of individuals who have failed therapy, who have an unclear
diagnosis, or who are engaged in a dispute with their employers.
We do not know the denominator, those patients who underwent
a successful surgical decompression of the thoracic outlet without
ever undergoing an IME. What you have shown us, it seems to
me, is that patients with upper extremity complaints who undergo
an IME likely don’t have neurogenic thoracic outlet compression.
Can you comment on this for us?
Dr Landry. The process of independent medical evaluation is
not to evaluate those who have failed therapy, but to evaluate all
patients who have a work-related complaint to determine the com-
pensability of their ailment with respect to their occupation. Some
of the patients that we evaluated had actually done quite well. Our
job was to evaluate whether or not what they had was related to
their occupation, not to make an assessment about optimal treat-
ment or to assess whether or not they had failed treatment.
Dr O. William Brown (Southfield, Mich). I’d like to congrat-
ulate you for addressing a very difficult problem. I would like to
ask you two questions.
First, how many patients in your series developed their tho-
racic outlet syndrome symptoms secondary to a previous identifi-
able trauma?
Secondly, when you speak of conservative therapy, was there
a specific conservative program protocol you followed, and if so,
what did it consist of?
Dr Landry. With respect to your first question, 50% of the
patients could relate the onset of their symptoms to an acute
event. The severity of that event was quite variable. The other
50% stated that they had a very gradual onset that they couldn’t
relate to a specific event.
Since we were not involved in the treatment of these patients,
I do not know what the extent of their conservative management
was. More than two thirds had been treated by a physical thera-
pist, and about 20% had seen a chiropractor, but beyond that I do
not know the extent of their conservative management.
Dr Frank C. T. Smith (Bristol, UK). This is a useful paper for
those of us who have to counsel patients with potential TOS, and
it will help, because we’re sometimes under considerable pressure
by those patients to perform surgery. My question relates to the
disputed and the undisputed diagnosis of TOS in your patients.
Did you rely solely on clinical examination, or did you find any
specific modalities of investigation useful in determining the
nondisputed TOS group?
Dr Landry. The diagnosis of disputed versus undisputed neu-
rogenic thoracic outlet syndrome was based heavily on the evalu-
ation of our neurologists. All of the patients were seen by a
neurologist. All of them underwent electrodiagnostic testing. The
diagnosis of true neurogenic thoracic outlet syndrome was based
on positive electrodiagnostic findings, specifically patients with
decreased amplitude of the median motor, ulnar sensory, or fre-
quently the median antebrachial cutaneous action potentials. The
findings were supported by abnormal electromyographic findings
in the lower plexus nerve distribution.
Dr Julie Ann Freischlag (Los Angeles, Calif). I actually had an
opportunity to read your manuscript, as Dr Machleder forwarded
that by e-mail to me, and he unfortunately can’t be here today. As
you all know, he’s the father of this, and because of that it’s taken
three of us at UCLA to take over his practice, because we see
quite a bit of neurogenic TOS.
I describe this disease to my patients as similar to alcoholism,
in the sense that it never will truly go away and they always will
have TOS. And certainly their perception of their disease is very
important. We use the scalene block in order for them to under-
stand exactly what will get better, what won’t, and whether it gets
better at all. And we utilize other people to do the scalene block
who will tell us it’s positive and then we do the surgery. We’re
actually using an SF-36 form preoperatively and postoperatively
now to try to assess if indeed we’re making these patients better,
as we tend to see a lot of them, and my nurse practitioner tends
to talk to a lot of them both preoperatively and postoperatively.
But I think perception is the big deal. These patients have to
understand how much better they can get and that they’re never
going to be able to go do everything they want and lift and do
things the way other people can.
My question to you is, did you use something like the SF-
36? Because asking somebody, “Are you okay?” I’m not sure is
good enough. In your paper not everyone was able to respond
to you. And I would say that most of the people with TOS that
decide to talk to you again are usually the ones that aren’t so
happy. Therefore, did you just ask if you’re okay, or did you use
a tool that’s been recommended in order to assess people’s qual-
ity of life?
I do agree we need a prospective, randomized study. We’d be
glad to participate, because I would love not to operate on half of
these people. And therefore, those of us who do a lot of these
operations would gladly participate in such a study.
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Thanks.
Dr Landry. Thank you for your question. We did not use the
SF-36. I think this is an excellent tool to use in prospective trials
to compare pretreatment and posttreatment evaluations.
Unfortunately, we didn’t have the opportunity to distribute a
questionnaire prior to our seeing these patients. So these results
are all retrospective.
What we did try to do was ask very specific questions relating
to their current level of arm function.
Dr John M. Porter. I will make one final observation. We ago-
nize over neurogenic thoracic outlet syndrome as much as any
condition that we happen to encounter in vascular surgery.
I make the following observation: Everywhere else in the
body, if you have pressure on a nerve, anatomic pressure, causing
pain, and no treatment is given, that nerve will eventually mal-
function. It will stop conducting impulses. It will stop perform-
ing motor functions. By that theory, assuming that there is no
way every neurogenic TOS patient in America has been treated
with decompression, we ought to have an epidemic of paralyzed
arms in our population, which we obviously do not have. It is
entirely possible that there is no such thing as disputed neuro-
genic thoracic outlet syndrome and that what we’ve been treating
is fibromyalgia or some other mystical rheumatologic condition.
These are interesting things for thought.
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